Our K2/Spice on-site test is the most sensitive K2 screen on the

market, detecting at 25 ng/mL both JWH-018 and JWH-073,

compounds used in the majority of K2 products. In fact, 98% of
K2 presumptive positive samples tested at a leading lab during
2011 contained at least one of these compounds.* The K2/Spice
Test also screens for six other compounds, giving it the widest
range of screened K2 compounds:
Name Compounds Detected by the K2/Spice Test
JWH-018 5-pentanoic acid metabolite
JWH-018 N-4-hydroxypentyl
JWH-073 4-butanoic acid metabolite
JWH-019 6-hydroxyhexyl
JWH-019 5-hydroxyhexyl
JWH-210 N-(5-carboxypentyl) metabolite C
26
H
25
NO
3
JWH-398 N-pentanoic acid metabolite
MAM2201 N-pentanoic acid metabolite
RCS-4 N-(5-carboxypentyl) metabolite C
21
H
21
NO
4
K2/Spice Test market-leading features:
Picks up more compounds than any other on-site test
The most sensitive K2 on-site test
more sensitive than many lab-based tests
The only consistently effective K2 on-site test
(see independent studies below)
The increased sensitivity of the our K2/Spice Test has been
established by an additional independent lab. Testing at a
conrming lab in New England reported that the K2/Spice Test
picked up the presence of K2 at less than 10 ng/mL.
Independent study
**
demonstrates
effectiveness of K2/Spice Test
K2 COMPARISON
K2/Spice
Test
Imported K2
product #1
Imported K2
product #2
Control Conc. NEG NEG NEG
Urine 1 N sample NEG NEG NEG
Urine 2 N sample NEG NEG NEG
Urine 3 N sample NEG NEG NEG
H2O Tapped NEG NEG NEG
JWH-018 25 ng/mL POS NEG NEG
JWH-073 25 ng/mL POS NEG NEG
MAM2201 100 ng/mL POS NEG NEG
JWH-398 200 ng/mL POS NEG NEG
JWH-210 300 ng/mL POS NEG NEG
JWH-018
(mg/g)
JWH-073
(mg/g)
CP47,497
(n=8)(mg/g)
JWH-250
(mg/g)
K2 Blonde 12 13 - -
K2 Standard 9 9 - -
K2 Citron 10 10 - -
K2 Summit 11 9 - -
K2 Blue 15 - - -
K2 Pink 11 - - -
K2 Latte 16 0.28 - 14
K2 Mint 19 0.30 - -
K2 Silver 8 - - 16
Spike Gold 20 11 - -
Spike Maxx 17 0.07 - -
Spike Silver 9 16 - -
Herbal blends* 2.0-35.9 - 1.1-16.9 -
Most sensitive K2 test on the market
K2 or Spice is an illicit drug that is
comprised of a mixture of herbs and spices,
typically sprayed with a synthetic compound.
The most common chemical compounds of K2
include JWH-018 and JWH-073.
* Norchem Drug Testing evaluation, April 2012 ** Study conducted October 3, 2012
Compounds present in popular K2 brands
301 Turman Street, Poteau, OK 74953
888-404-0020 | Fax 918-649-1005
www.rapiddetect.com
Manufactured for:
Forensic use
or export only
K2 or Spice is an illicit drug that is comprised of a mixture of herbs and
spices, typically sprayed with a synthetic compound that is chemically
similar to THC, the psychoactive ingredient in marijuana. The most common
chemical compounds of K2 include HU-210, HU-211, JWH-018, and
JWH-073. K2 is often marketed in head shops, tobacco shops, or over the
Internet as incense or fake weed. Unknown product origin and amount of
chemical compound on the organic material are just two of the many risks
associated with K2/Spice.
Street names
Bliss, Black Mamba, Bombay Blue, Cloud Nine, Fake Weed, Genie, Spice,
Zohai
Looks like
K2 is typically sold in small, silvery plastic bags of dried leaves and marketed
as incense that can be smoked. It is said to resemble potpourri.
Methods of abuse
K2 products are usually smoked in joints or pipes, but some users make it
into a tea.
Affect on mind
Psychological effects are similar to those of marijuana and include paranoia,
panic attacks, and giddiness.
Affect on body
Physiological effects of K2 include increased heart rate and increase of
blood pressure. It appears to be stored in the body for long periods of time,
and therefore the long-term effects on humans are not fully known.
Drugs causing similar effects
Marijuana
Overdose effects
There have been no reported deaths by overdose.
Legal status in the United States
On Tuesday, March 1, 2011, DEA published a nal order in the Federal
Register temporarily placing ve synthetic cannabinoids into Schedule I of
the CSA. The order became effective on March 1, 2011. The substances
placed into Schedule I are 1-pentyl-3-(1-naphthoyl) indole (JWH-018),
1-butyl-3-(1-naphthoyl) indole (JWH-073), 1-[2-(4-morpholinyl) ethyl]-
3-(1-naphthoyl)indole (JWH-200), 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-
hydroxycyclohexyl]-phenol (CP-47,497), and 5-(1,1-dimethyloctyl)-2-
[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol; CP-47,497
C8 homologue). This action is based on a nding by the Administrator
that the placement of these synthetic cannabinoids into Schedule I of
the CSA is necessary to avoid an imminent hazard to the public safety.
As a result of this order, the full effect of the CSA and its implementing
regulations including criminal, civil and administrative penalties, sanctions,
and regulatory controls of Schedule I substances will be imposed on the
manufacture, distribution, possession, importation, and exportation of these
synthetic cannabinoids.
Common places of origin
Manufacturers of this product are not regulated and are often unknown
since these products are purchased via the Internet whether wholesale
or retail. Several websites that sell the product are based in China. Some
products may contain an herb called damiana, which is native to Central
America, Mexico, and the Caribbean.
Source: dea.gov Drug Fact Sheet: K2 or Spice
DRUGS TESTS AVAILABLE IN DIP CASSETTE OR SINGLE STRIPS
301 Turman Street, Poteau, OK 74953
888-404-0020 | Fax 918-649-1005
www.rapiddetect.com
RDI269C 0513
Manufactured for:
URINALYSIS CUTOFFS
Alcohol (ALC) .04%*
Amphetamine (AMP) 1,000
500*
300*
Barbiturates (BAR) 300
Benzodiazepines (BZO) 300
200*
Buprenorphine (BUP) 10
5*
Cocaine (COC) 300
150
Cotinine (COT) 200*
EDDP 100*
Fentanyl (FYL) 200*
GHB 10*
Ketamine (KET) 1,000*
K2/Spice 25*
Marijuana (THC) 300*
50
25*
Methadone (MTD) 300
Methamphetamine
(MET)
1,000
500
300*
Methylenedioxymeth-
amphetamine (MDMA)
500
Opiates (OPI) 2,000
300
Oxycodone (OXY) 100
Phencyclidine (PCP) 25
Propoxyphene (PPX) 300
Tramadol (TML) 100*
Tricyclic Antidepressants
(TCA)
1,000
* FORENSIC USE ONLY
All cutoffs in ng/mL except
alcohol (%BAC) and GHB (mg/mL)